Summary
None of the listed claims can be verified as supported by FDA Lipitor prescribing information because only section headings were provided (no actual label text). Therefore, all claims must be treated as unsupported/absent from the provided label content.
Category Scores
Accurate Statements
Unsupported Statements
Lipitor (atorvastatin) lowers cholesterol.
No supporting FDA label text was provided in the prompt for any section.
Lipitor does not directly deplete potassium levels like some diuretics.
No supporting FDA label text was provided in the prompt for any section.
Statin users may face muscle cramps or fatigue.
No supporting FDA label text was provided in the prompt for any section.
Doctors often recommend potassium-rich foods unless kidney issues or other medications (like ACE inhibitors) raise hyperkalemia risk.
No supporting FDA label text was provided in the prompt for any section.
Bananas contain about 420 mg potassium per medium banana.
No nutrition/food-potassium content is present in provided FDA label sections.
Cooked spinach contains about 840 mg potassium per 1 cup serving.
No nutrition/food-potassium content is present in provided FDA label sections.
A medium baked sweet potato contains about 540 mg potassium.
No nutrition/food-potassium content is present in provided FDA label sections.
Half an avocado contains about 485 mg potassium.
No nutrition/food-potassium content is present in provided FDA label sections.
Plain low-fat yogurt contains about 380 mg potassium per 6 oz serving.
No nutrition/food-potassium content is present in provided FDA label sections.
Cooked salmon contains about 380 mg potassium per 3 oz.
No nutrition/food-potassium content is present in provided FDA label sections.
White beans contain about 500 mg potassium per 1/2 cup canned serving.
No nutrition/food-potassium content is present in provided FDA label sections.
The claim that these potassium-rich foods provide 300–600 mg potassium per serving is made.
No food-potassium dosing/range content is present in provided FDA label sections.
The U.S. dietary guidelines recommend aiming for 4,700 mg daily potassium from food.
Dietary guidelines/targets are not provided in the prompt’s FDA label sections.
The advice given is to spread daily potassium intake across meals to avoid GI upset.
No dietary counseling content was provided in the prompt’s FDA label sections.
High-potassium choices like oranges, potatoes, or dried apricots are fine in moderation.
No food-specific guidance was provided in the prompt’s FDA label sections.
The recommendation is to skip salt substitutes that are potassium chloride-based without doctor approval.
No guidance about potassium chloride salt substitutes is provided in the prompt’s FDA label sections.
The text claims potassium chloride-based salt substitutes can interact indirectly with statins via blood pressure medications.
No interaction content involving potassium chloride salt substitutes was provided in the prompt’s FDA label sections.
No direct Lipitor–potassium food bans exist.
No label text about any Lipitor-related food bans for potassium-containing foods was provided.
Studies show no significant potassium drop from Lipitor alone.
No study findings about potassium change with Lipitor were provided in the prompt’s FDA label sections.
Rare cases link statins to mild hypokalemia via muscle effects.
No label text was provided that links statins to hypokalemia via muscle effects.
The text claims the incidence of hypokalemia in trials is under 1%.
No trial incidence data for hypokalemia was provided in the prompt’s FDA label sections.
Blood tests monitor electrolytes during long-term Lipitor use.
No monitoring guidance/electrolyte testing recommendations were provided in the prompt’s FDA label sections.
Excess potassium risks arrhythmias in people with kidney disease, diabetes, or those taking spironolactone or amiloride.
No label text addressing potassium/arrhythmia risk tied to these patient groups or drugs was provided.
The recommendation is to get potassium levels checked before ramping up intake.
No label text providing pre-intake potassium testing guidance was provided.
Contradictions
Important Omissions
Boxed warnings, contraindications, and specific Warnings/Precautions, Adverse Reactions, Drug Interactions, and Use in Specific Populations content were not provided as actual label text; therefore, the response’s alignment or conflicts with these high-safety sections cannot be evaluated.
Importance:
High
Safety Assessment
Potential Patient Risk:
Low
This audit cannot determine correctness or safety vs. FDA labeling because the prompt lacked actual label text; however, the response includes many statements not supported by the provided label content, limiting on-label verification.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
All substantive claims are unverified against FDA label text because only section headings were provided; therefore the claims are treated as unsupported/absent from the label content.
Suggested Improvement
Provide the actual FDA label text (not just section headings) for the relevant sections (12, 5, 6, 7, 8) or remove/limit non-label statements. Ensure each claim is directly supported by the provided label wording.